Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myosin phosphatase Rho interacting protein pseudogene 1 (MPRIPP1) is a human pseudogene located on chromosome 3 (genomic position 3:44,579,937, ENSEMBL ID: ENSG00000214820, NCBI Gene ID: 100421374). As a pseudogene, MPRIPP1 shares sequence similarity with functional protein-coding genes (in this case, broadly related to myosin phosphatase Rho-interacting proteins) but has accumulated disabling mutations, such as frameshifts or premature stop codons, rendering it unable to produce a functional protein product. Pseudogenes like MPRIPP1 may sometimes be transcribed into RNA and can indirectly regulate gene expression (for example, via the competing endogenous RNA mechanism or as miRNA decoys), but there are no published reports of such function specific to MPRIPP1. MPRIPP1 is not categorized as a therapeutic target. Key point: MPRIPP1 is a pseudogene and not a druggable receptor, enzyme, transporter, or similar therapeutic target, so it does not meet the criteria generally required for molecular drug targeting or biomarker use in current biomedical contexts.
None, as this is not a target for drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myosin phosphatase Rho interacting protein pseudogene 1 (MPRIPP1).